InvestorsHub Logo
Followers 65
Posts 23924
Boards Moderated 0
Alias Born 11/23/2016

Re: abew4me post# 414915

Thursday, 05/11/2023 12:31:08 PM

Thursday, May 11, 2023 12:31:08 PM

Post# of 462570
You see as I have saying all along that a PM P3 is very like required. That now seems something like 100% the case.

I have also been saying that if the new disease specific biomarkers, stated under other outcome measures, were to prove strongly correlated to response and clinical benefits - then AA out of the P2b/3 might be possible. Well actually the P2b trial - full stop.

Given what we have now heard from Missling, it seems this could be a potential pathway to AA. I keep my expectations low on this and hope for good news.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News